In this study, we analyzed the relationships of exercise capacity by the percentage of predicted FEV 1 (4). Celli proposed a and health status to mortality in patients with chronic obstructive systemic evaluation of COPD patients and stressed that there pulmonary disease (COPD). We recruited 150 male outpatients with is a need to seek candidates for multidimensional disease parameters, including exercise capacity and health status, and ysis revealed that the peak oxygen uptake and the SGRQ total score mortality in patients with COPD after 5 years. In addition, were both predictive of mortality, independent of FEV 1 and age.
Mortality has been an important outcome in chronic obstrucies likely to affect mortality such as malignant disorders, cardiovascular tive pulmonary disease (COPD), as it is currently the fourth diseases, or cerebrovascular diseases; (4 ) regular attendance over 6 months; and (5 ) no exacerbations in the preceding 6 weeks. Pulmonary leading cause of death in the world (1) . The disease severity function, exercise capacity, health status, smoking status, and body mass of COPD has been based on the degree of airflow limitation, index (BMI) were evaluated on the same day. Pulmonary function as defined by FEV 1 because FEV 1 has been regarded as the tests were performed at least 12 hours after the withdrawal of inhaled most important predictor of mortality in addition to age (2).
bronchodilators. According to the recommended method (9), subjects However, although many studies investigating factors related underwent spirometry before and at 15 and 60 minutes after inhaling to mortality have been performed in COPD, the relationships salbutamol (400 g) and ipratropium bromide (80 g) using a meteredof exercise capacity and health status to mortality have rarely dose inhaler with a spacer device (InspirEase; Schering-Plough K.K., been evaluated.
Osaka, Japan) (10). The predicted values were those established by the There has recently been some debate about the use of Japan Society of Chest Diseases (11) . Self-reported smoking status was FEV 1 as the main single evaluative parameter for COPD.
confirmed by using a smokerlyzer and measuring plasma cotinine levels as explained elsewhere (12 recently reported that categorizing patients with COPD on the level of dyspnea was more closely correlated with mortalMeasurements ity than classification based on disease severity, as assessed Symptom-limited progressive cycle ergometry was performed 60 minutes after the inhalation of bronchodilators on a calibrated, electrically braked cycle ergometer (13). Patients wore a face mask and began unloaded pedaling for 3 minutes, after which the workload was increased progressively by increments of 1 W every 3 seconds to the sum. The SGRQ consists of 50 items divided into three components When the patients were classified according to COPD severity of symptoms, activity, and impacts, and the total score was also calcubased on airflow limitation defined by the American Thoracic lated, with scores ranging from 0 to 100. The BPQ has 33 items, and Society, 63 patients (42%) were in stage I (50% or more preits total score was calculated using a scale of 1 to 103. Higher scores dicted). Forty-eight (32%) were in stage II (35-49% predicted), indicate less impairment on the CRQ, and the opposite is true of the SGRQ and BPQ.
and thirty-nine (26%) were in stage III (less than 35% predicted). Kaplan-Meier survival curves based on the severity of airflow
Statistical Analysis
limitation are presented in Figure 1 .
Results are presented as mean Ϯ SD unless otherwise stated. The
Among the 150 patients enrolled, 6 were unavailable for survival status of all subjects after 5 years was assessed. The duration from entry to the last attendance or death was recorded. The survival time was calculated with the life table method. Univariate and multivariate Cox proportional hazards analyses were performed to investigate the relationship between the clinical indices and mortality. Postbronchodilator FEV 1 was used as an index of airflow limitation because it is regarded as a better predictor of mortality than prebronchodilator FEV 1 (2). Clinical variables were used as continuous variables, except that the categoric variables of smoking status and the use of inhaled corticosteroids were coded as one or zero for the analysis. Results of the regression analysis were presented in terms of the estimated relative risks (RRs) with corresponding 95% confidence intervals; p values of less than 0.05 were considered to be statistically significant.
RESULTS
The baseline characteristics of the 150 male COPD patients are presented in Table 1 . Their age averaged 68.7 Ϯ 6.9 years, and postbronchodilator FEV 1 was 47.4 Ϯ 17.4% predicted. Five patients received no medications, and 145 patients were treated with both inhaled short-acting ␤ 2 -agonists and anticholinergic agents. Sixteen patients (11%) received oral theophylline (400 high doses (1,600 to 2,400 g/day) of inhaled beclomethasone follow-up over the 5-year period (follow-up rate 96%), and 31 and 4). With respect to exercise capacity, when entering peak had died. The survival rates at 1, 3, and 5 years were 95%, 90%, V o 2 , age, and FEV 1 as explanatory variables, peak V o 2 turned and 80%. Of the causes of deaths, 20 patients died due to COPD out to be more strongly correlated with mortality than age or or COPD-related diseases, 4 due to malignant disorders, includ-FEV 1 (Table 3) . Regarding health status, the SGRQ total score ing 2 lung cancer cases, and 1 each due to myocardial infarction was used as an index because it was more significantly related and hepatic failure, respectively. Five deaths were due to unto mortality than the total scores on the CRQ or BPQ. When known reasons.
entering the SGRQ total score, age, and FEV 1 as explanatory Univariate Cox proportional hazards analysis was performed variables, all were significantly correlated with mortality to investigate the relationship between the clinical measures and (Table 4) . However, the relationship between the SGRQ total mortality (Table 2) . Age, BMI, FEV 1 , diffusing capacity for carscore and mortality was weaker as compared with age and FEV 1 . bon monoxide/Va, and peak V o 2 were all significantly related To analyze which index was the most significantly correlated to survival (RR ϭ 1.091, p ϭ 0.0021; RR ϭ 0.785, p ϭ 0.0005; with mortality, stepwise Cox proportional hazards analysis was RR ϭ 0.940, p Ͻ 0.0001; RR ϭ 0.413, p Ͻ 0.0001; and RR ϭ 0.994, performed using age, cumulative smoking, BMI, FEV 1 , diffusing p Ͻ 0.0001, respectively). Although the relationship between capacity for carbon monoxide/Va, peak V o 2 , and the SGRQ smoking status at baseline and mortality was not significant (p ϭ total score. This analysis revealed that peak V o 2 and age were 0.56), cumulative smoking evaluated by the total pack-years was the most significant factors related to mortality (RR ϭ 0.994, significantly correlated with mortality (RR ϭ 1.010, p ϭ 0.022). p Ͻ 0.0001; RR ϭ 1.077, p ϭ 0.024, respectively) ( Table 5) . Regarding health status, the CRQ dyspnea domain was signifi- Figure 2 shows Kaplan-Meier survival curves using quartiles of cantly correlated with mortality (RR ϭ 0.921, p ϭ 0.0047); howthe peak V o 2 distribution. ever, the other three domains and the total score on the CRQ were not correlated with mortality. In contrast, activity, impacts,
DISCUSSION
and the total scores on the SGRQ and the total score on the We have evaluated the factors related to mortality in COPD, BPQ had strong relationships with mortality (RR ϭ 1.038, p ϭ particularly the relationships of exercise capacity and health 0.0001; RR ϭ 1.029, p ϭ 0.0023; RR ϭ 1.033, p ϭ 0.0017; and status to mortality. We have found that exercise capacity and RR ϭ 1.035, p ϭ 0.0044, respectively).
health status were significantly predictive of mortality in COPD, To compare the ability of exercise capacity and health status independent of airflow limitation or age. In addition, this study to predict mortality versus that of airflow limitation and age, indicates that exercise capacity can be the best predictor of which have been considered to be the best predictors of mortality (2), multivariate regression analysis was performed (Tables 3  mortality in patients with COPD. Furthermore, the ability of health status to predict mortality turned out to be different SGRQ and the BPQ were strongly and significantly correlated with mortality; however, the CRQ total score was not signifidepending on the instruments used.
TABLE 4. MULTIVARIATE COX PROPORTIONAL HAZARDS ANALYSIS TO INVESTIGATE THE RELATIONSHIPS BETWEEN HEALTH STATUS, AGE, AND AIRFLOW LIMITATION WITH MORTALITY IN MALE PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Regarding exercise capacity, one novel finding in this study cantly correlated. Gerardi and coworkers (17) also failed to show a significant relationship between the CRQ and the 3-was that it could be the most significant criterion related to mortality among age, pulmonary function, BMI, or health status year survival rate after pulmonary rehabilitation in patients with advanced pulmonary disease. However, recent studies have rewhen using peak V o 2 as an index. Exercise capacity of COPD patients is affected by important, complex factors, including venported a significant relationship between health status and mortality using the SGRQ (22, 23) . tilation, gas exchange, circulation, muscular function, nutritional status, and their symptoms (7); hence, COPD can be regarded Why was the CRQ less correlated to mortality than the SGRQ and the BPQ? First, the CRQ does not examine activity restricas a systemic disorder (6) . Exercise capacity may thus evaluate the severity of COPD more comprehensively and objectively tions, unlike the SGRQ and BPQ (24) . Therefore, the patients may not be well discriminated based on the severity of their than airflow limitation defined by FEV 1 . Furthermore, exercise capacity cannot be accurately predicted from resting physiologic functional status, which is a significant factor closely correlated with mortality (18). Wijkstra and coworkers (25) also reported variables (7) . Therefore, in addition to resting spirometric testing, exercise capacity can be measured as an index of disease that functional exercise capacity was not adequately evaluated by the CRQ. In addition, Hajiro and coworkers (12) showed severity from the perspective of mortality in patients with COPD.
A few studies have reported the importance of exercise capacthat the CRQ had relatively lower correlations with pulmonary function, exercise capacity, and dyspnea but was more influenced ity as a predictor of mortality in COPD (2, 17, 18). However, the indices of exercise capacity in these studies were the maximal by psychologic status than the SGRQ or BPQ. These differences in the physical versus psychologic aspects might have contributed work rate (2) and the walking distance (17, 18) , and an analysis of the gas expired during exercise was not performed. Peak to these results. Second, the CRQ has a seven-point Likert scale but includes only 20 items. In comparison, the SGRQ and BPQ V o 2 is the primary measure of exercise capacity; the prognostic significance of peak V o 2 has not, however, been previously evaluhave a lower response range to each item but more items than the CRQ. Therefore, the CRQ would be better at investigating ated in COPD. When investigating the relationship with mortality in COPD, peak V o 2 might be preferable, as it was more the changes within individuals but weaker at discriminating between patients based on various aspects for assessing health significantly correlated to mortality than any of the other measures.
status. This point might also have affected the ability of the CRQ to predict mortality. This study demonstrated that health status had a significant correlation with mortality independent of airflow limitation or In this study, BMI was not a significant prognostic factor in the multivariate analysis as observed by Bowen and coworkers age. The role of health status in predicting mortality has not been previously evaluated well in COPD, although the association (18) , although some studies have reported a significant relationship (26, 27) . In the Copenhagen City Heart Study (26) , the between health status and subsequent mortality has been frequently reported for cancer (19, 20) . In addition, a novel finding association between BMI and mortality was especially significant in severe COPD and differed according to the severity of airflow was the different abilities of health status measures to predict mortality. Predicting future outcomes is one important objective limitation. We made only an overall analysis of COPD due to the smaller sample size in this study. In contrast, we included of measuring health status (21) , and therefore, it may be insightful to compare different measures from the viewpoint of some detailed potential prognostic factors such as exercise capacity and diffusing capacity, which have been shown to be related their predictive properties. In this study, the total scores on the (34) . Therefore, we should have searched for a better way to investigate the relationship between comorbidities and survival. Second, it is not well known how accurate a face mask is in the determination of peak V o 2 in comparison to a mouthpiece. Although breathing pattern may change according to types of breathing assembly (35), it was reported that this did not alter maximal exercise (36). To find the individual maximal V o 2 is difficult because peak V o 2 will change depending on exercise apparatus, incremental work rate, and so on (37) . However, we believe that the more accurately peak V o 2 is calculated, the stronger the significant relationship between peak V o 2 and mortality becomes.
In conclusion, we demonstrated significant relationships of exercise capacity and health status to mortality in COPD patients, independent of FEV 1 or age. Laboratory exercise capacity using the cycle test could be the most significant predictor of mortality in COPD. With respect to health status, the ability of the CRQ to predict mortality was weaker than the SGRQ or BPQ. Although airflow limitation has been traditionally used as the index of disease severity in COPD, as it is regarded as the most significant predictor of mortality, the findings of this study will have a potentially great impact on the multidimensional evaluation of the disease severity in COPD from the perspective to nutritional status (28) . These may explain the insignificant of mortality. relationship to BMI in this study.
This study demonstrated that cumulative smoking was a significant predictor of mortality in the univariate analysis but that
